Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as contrast agent: a Smart Way to Future Nanomaterials for Nanomedicine Applications by Aouidat, Fatima et al.
HAL Id: hal-02337580
https://hal.archives-ouvertes.fr/hal-02337580
Submitted on 29 Oct 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Design and Synthesis of Gold-Gadolinium-Core-Shell
Nanoparticles as contrast agent: a Smart Way to Future
Nanomaterials for Nanomedicine Applications
Fatima Aouidat, Sarah Boumati, Memona Khan, Frederik Tielens, Bich-Thuy
Doan, Jolanda Spadavecchia
To cite this version:
Fatima Aouidat, Sarah Boumati, Memona Khan, Frederik Tielens, Bich-Thuy Doan, et al.. Design
and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as contrast agent: a Smart Way to Future
Nanomaterials for Nanomedicine Applications. International Journal of Nanomedicine, Dove Medical
Press, In press. ￿hal-02337580￿
1 
 
1 
 
 
 
 
Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as contrast agent: a 
Smart Way to Future Nanomaterials for Nanomedicine Applications. 
 
Fatima Aouidat
1
, Sarah Boumati
2
, Memona Khan
1
, Frederik Tielens
3
, Bich-Thuy Doan
2
 and 
Jolanda Spadavecchia
1* 
 
1
 CNRS, UMR 7244, CSPBAT, Laboratoire de Chimie, Structures et Propriétés de 
Biomatériaux et d’Agents Thérapeutiques Université Paris 13, Sorbonne Paris Cité, 
Bobigny, France. 
2
 UTCBS – Chimie ParisTech – Université Paris Descartes - CNRS UMR 8258 – INSERM 
U1022 Equipe "Synthèse, Electrochimie, Imagerie et Systèmes Analytiques pour le 
Diagnostic" SEISAD, 11 Rue Pierre et Marie Curie, 75231 Paris Cedex 05. 
3
 General Chemistry (ALGC), Vrije Universite it Brussel (Free University Brussels-VUB), 
Pleinlaan 2, 1050 Brussel, Belgium. 
 
 
*
 
Corresponding author: jolanda.spadavecchia@univ-paris13.fr 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
2 
 
ABSTRACT 
Introduction. The development of biopolymers for the synthesis of Gd (III) nanoparticles, as 
therapeutics, could play a key role in nanomedicine. Biocompatible polymers are not only 
used to complex monovalent biomolecules, but also for the realization of multivalent active 
targeting materials  as diagnostic and/or therapeutic hybrid nanoparticles. In this paper, it was 
reported for the first time, a novel synthesis of Gd (III)-biopolymer–Au (III)-complex, acting 
as a key ingredient of core-shell gold nanoparticles (Gd(@AuNPs). 
Material and Methods. The physical and chemical evaluation was carried out by 
spectroscopic analytical techniques (Raman spectroscopy, UV-Visible and TEM). The 
theoretical characterization by DFT (Density Functional Theory) analysis was carried out 
under specific conditions to investigate the interaction between the Au and the Gd precursors, 
during the first nucleation step. Magnetic features with relaxivity measurements at 7T were 
also performed as well as cytotoxicities studies on hepatocytes cell lines for biocompatibility 
studies. The in vivo detailed of dynamic biodistribution studies in mice to characterize the 
potential applications for biology as MRI contrast agents were then achieved.  
Results. The principal aim of  this study is to apply a Gd@Au chloride complex as building 
blocks of bimetallic nanoparticles under specific conditions of the reaction. Physical –
Chemical evaluation by several techniques and computational  studies confirms the successful 
of the design and reaction ipothysed. Viabilities of TIB-75 (hepatocytes) cells were evaluated 
using Alamar blue cytotoxic tests with increasing concentrations of nanoparticles. In vivo 
biodistribution studies were then accomplished to assess the kinetic behavior of the 
nanoparticles in mice and characterize their stealthiness property after intravenous injection. 
Conclusion. We demonstrated that Gd@AuNPs have some advantages to display 
hepatocytes in the liver. Particularly, these nanoconjugates give a good cellular uptake of 
several quantities of Gd @NPs into cells, while preserving a T1 contrast inside cells that 
provide a robust in vivo detection using T1-weighted MR images.These results will 
strengthen the role of gadolinium as complex to gold in order to tune Gd(@AuNPs, as 
innovative diagnostic agent in the field of nanomedicine. 
Key words: Gd-Gold complex; theoretical study; MRI; relaxivity; biodistribution. 
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1. Introduction 
In recent decades, hybrid nanomaterials have been intensively investigated in the field of 
nanomedicine
1-3
, diagnosis
4
, and imaging
5,6
. The consolidation of several functional materials 
into nanocomposites, make up new opportunities in order to improve a variety of emerging 
applications of hybrid nanomaterials.
7-9
 
The application area in which nanoparticles have obtained remarkable profit is in the 
biomedical field and in particular in diagnostic imaging
10
. Several  types of nanoparticles 
have been inquiring for several imaging applications which includes biomolecules
11
, metal 
oxides
12
, and semiconducting nanomaterials
13
.  Recently, gold nanoparticles (AuNPs) have 
been regarded as the common   choice of imaging contrast and theranostic agents due to their 
optochemical  properties, biological efficiency as  biomarkers, strong X-ray absorption 
coefficients and efficient high-Z nanoparticle radio-enhancement , NIR light responsive 
agentto create nanosized contrast agents with molecular specificity
14-16
 .The nanoparticles 
selected is dependent upon the required imaging modality
17
; gadolinium (Gd), owns a wide 
magnetic moment and seven unpaired electrons in the external shell, which are carried out as 
a clinical positive contrast agent for MRI as chelates
18
. Although, the clinical contrast agents 
for CT (cancer treatment) are principally based on tri-iodobenzene, which can effectively 
absorb X-rays. Unfortunately, the short circulation time of the Gd chelates and iodinated 
compounds, due to the nature of the small molecules under a few nanometer sizes, can limit 
the relative imaging technique from reaching the pathologic tissue of interest to be detected 
and from collecting the prerequisite information. Moreover, it is laborious to promote the 
grafting of small molecules for active targeting
19
.  
Nanomaterials based on Gd (III) and AuNPs have recently showed significantly increased 
relaxivity values in Magnetic Resonance Imaging (MRI) due to geometrical confinement of 
Gd(III)-chelate compounds into porous structures compared to those with free chelated Gd 
(III)complexes
20
. 
The payload of gadolinium, particularly under its Gd (III) form in NPs structures, has a 
notable effect in plenty of research fields from plasmonics to nanomedicine applications.
21-23
 
Nevertheless, strategies to load NPs as contrast agents used in MRI, in harsh or poor loading 
conditions, result in NP surface modifications that alter the targeting in vivo.
24
 
To provide a safe application in biological media, and to understand the importance of 
cationic metals in biological systems (charge balancing, stabilizing structures, catalyzing 
reactions, …), gadolinium ions must be chelated to prevent the release of metal in the body. 
Another option could be the incorporation of the cations in “safe” nanostructures, and keeping 
4 
 
4 
 
in mind that also the final design of the complex-hybrid NP might combine both options after 
being assembled together. In the recent literature, a fast  synthesis method to develop 
polymer-modified AuNPs using biopolymers as stabilizers, under biological conditions
25-27
 
have been described. Other authors have synthesized and described hybrid nanoparticles 
based on sugar stabilizers for different applications in nanomedicine
28
. 
In this paper, three bimetallic nano formulations (Gs@AuNPs) named NP1, NP2, and NP3, 
including Au-Gd complex wrapped into a biopolymer structure were designed and 
synthetized. Furthermore, these nanovectors including paramagnetic Gd (III) ions provided 
potential interesting magnetic for MRI imaging. 
The purpose of the study is also the development of innovative molecular imaging methods 
based on dynamic recording of the uptake, and clearance of novel imaging probes. Indeed, the 
quantitative pharmacokinetics of theranostic nanovectors allowed to study the in vivo 
behavior, necessary to determine the stealthiness and targeted property of the probes, and 
supply the final biomolecular mapping for the determination of the diagnosis and the 
efficiency of a therapy. These novel perspectives will have a decisive impact on the evolution 
of high hybrid nanomaterials used in nanomedicine. 
 
2. Experimental Section  
2.1.Materials 
Tetrachloroauric acid (HAuCl4
*
3H2O), Gadolinium chloride hexahydrate 
(GdCl3
*
6H2O),sodium borohydride (NaBH4), phosphate buffer solution (PBS, pH4.0, 7.2-
9.0), sodium chloride (NaCl),culture media cell (DMEM) , dicarboxylic polyEthylene glycol 
(PEG)-600 (PEG), collagen Type I from calf skin (COL), chitosan (Deacetylated 
chitin, Poly(D-glucosamine) (CHIT),were purchased from Sigma-Aldrich (Saint-Quentin 
Fallavier, France). All chemicals were used as such without further purification. Milli Q water 
was used throughout the experiments.  
TIB-75 cell line was purchased from ATCC ( Americal Type Culture Cells. USA). 
4.2. Physical chemical characterization  
All characterizations were performed in triplicate in order to confirm the reproducibility of the 
synthetic and analytical procedures
29
. 
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UV-Vis absorption spectroscopy: 
As previously mentioned, absorption spectra were recorded in the 350-900 nm spectral range 
in water at Gd@AuNPs concentration equal to 0.28mM for [Au]and 13.94mM for [Gd]. 
 
Transmission Electron microscopy (TEM): Transmission Electron Microscopy  was 
performed as previously described
24
. 
 
Scanning Electron Microscopy-Energy dispersive x-Ray analysis (SEM-EDX): Scanning 
electron microscopy (SEM) investigation was performed on an environmental SEM (ESEM, 
Quanta 200 FEG, FEI Company Hillsboro, OR) equipped with an (EDX) spectrometer 
(Genesis 2000, XMS System 60 with a Sapphire Si/Li Detector from EDAX Inc., Mahwah, 
NJ).  
Raman Spectroscopy: The Raman experiments were carried out as previously described
24
.  
 
Dynamic light scattering (DLS): DLS analysis were performed as described previously
24
 
 
Zeta potential measurements: The zeta potential of Gd@AuNPsin aqueous solution, was 
carried out as described above 
24
 
2.3. Release kinetics under acidic conditions 
Release of the Gd@AuNPs was carried out in buffers of pH 4.0 under specific conditions
20
. 
In a glass vial, 1mL of Gd@AuNPs were dissolved in 50 µL of phosphate buffer of required 
pH and take on stirring at 37°C of temperature. After 10 min of time, 1 mL of dispersion was 
withdrawn and centrifuged to separate the dye (rose bengale RB) released from the particles.
30
 
Amount of RB released from the NPs was evaluated by measuring its absorbance at 549 nm 
in supernatant
30
.  
2.4. Cytotoxicity Test 
The cytotoxicity was determined on TIB-75 hepatocytes using the Alamar blue test. The cells 
were cultured at 37°C in DMEM + Glutamax containing 10% fetal bovine serum (FBS, Gibco 
Life Technologies), in 96 wells plaques 100 µM of streptomycin, and 100 units/mL of 
penicillin. They were maintained in a 5% CO2-humified atmosphere and passaged twice a 
6 
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week by removing the adherent cells with 0.05 % Trypsin- EDTA. Fluorescence 
measurements at 570 nm were performed on a TECAN Infinite 200 plaque reader and IC50 
was assessed from the normalized values using Graphpad Prism software. 
2.5. In vitro relaxivities studies 
Samples of MNPs and UMLs were diluted in injection buffer (0.108 M NaCl, 0.02 M sodium 
citrate and 0.01 M HEPES) at various concentrations of Gd (0, 0.1, 0.5, 1.0, 3 mM). 
In vitro relaxivity experiments were carried out by recording T1 and T2 maps with a 7T MR 
imaging vertical spectrometer fitted with an ultra-shielded refrigerated magnet (300WB, 
Bruker, Avance II, Wissembourg, France), and equipped with a nominative 200 mT/m 
actively shielded gradient. The software Paravision 5.1 allowed the acquisitions with the 
following parameters: for T1 map: RARE images ; TE = 13ms ; TR = 15 s, 8 s, 3 s, 1.2 s, 0.8 
s, 0.594 s, 0.3 s, 0.144 s, 0.05 s, 0.033s, RARE factor 2; for T2 map: multi-echo MSME 
images: hermitian pulse, TR/TE = 15 s/11 ms, 32 echos. Fields of view of 3 x 3cm², a matrix 
size of 128 x 64 and a slice with a thickness of 1.5mm were used for T1 and T2 maps. 
Relaxation times T1, T2 and T2
*
 of each sample were calculated by fitting (for T1:
 ; for T2 and T2
*
 :  ). 
 
Molar relaxivities r1, and r2 in mM
-1
.s
-1
 were obtained using the following equation: 
(1)       with y: 1 or 2. 
2.6. In vivo biodistribution studies by MRI 
Biodistribution studies were achievedin vivo by MRI
21
to assess the uptake and clearance from 
kidney, muscle, spleen, liver more easily observable by MRI, a non invasive in vivo 
bioimaging method. 
All animal work was performed in accordance with the institutional animal protocol 
guidelines in place at the University Paris Descartes, saisine CEEA34.JS.142.1 and approved 
by the Institute’s Animal Research Committee. 
Wild-type female 8 weeks BALB/c mice were anaesthetized by Isoflurane (1.5% air/O2 
0.5/0.25 L.min
-1
) inhalation and positioned into a dedicated contention cradle with monitoring 
of the breath, and temperature of the animal thanks to specific detectors. 100 µL of 
Gadolinium Au nanoparticles in saline 0.9% with an optimized concentration of 10 mM of Gd 
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were intravenously injected via the tail vein through a dedicated non magnetic 30G catheter 
while the mouse was in the scanner. One agent (NP3) was imaged representative of the series 
of agent with n=6 mice for reproducibility. 
Images were acquired at 7 Tesla (300 MHz) micro imaging spectrometer (Bruker, Karlsruhe 
Germany) previously described
51
. 
The scanning protocol was developed using Paravision 5.1 software. 
After positioning anatomic slice recorded in axial directions to locate the different organs of 
the mice, DCE Dynamic Intragate Flash for motion free artifacts and multislicesT1weighted 
sequence images were recorded. The final images have a spatial resolution of 117 µm x 117 
µm in plane. The scan time was in the order of 3 min 14 s per images which were sequentially 
recorded before and after the contrast agent injection. The dynamic follow-up is measured 
during a first scan time of 40 min, then at 3h, 6h, 24h and 48 hours post injection. 
To study the biodistribution of the nanoparticles, post processing of the dynamic images 
consists in delineation and monitoring of several regions of interest (ROI) into the mouse 
body MRI images, the liver, muscle, spleen and the kidney. The corresponding MRI 
intensitiesrelated to the amount of the nanoparticles contrast agent wereplotted against time to 
visualize the uptake and clearance of the Gd scaffolds in the organs. Comparison with 
commercial DOTA-Gd (Guebert, France) as a reference was also performed at the 
corresponding concentration of Gd (10 mM). Uptake, permanence and clearance times were 
visually assessed and semi quantitative kinetic parameters were measured from the dynamic 
curves and compared to the novel contrast agent. 
2.7. Stability of Gd@AuNPs  
The stability of Gd@AuNPswas monitored by UV VIS. All nanoparticles were dissolved in 
culture media (DMEM + 10% FBS) solution during 72 h (Figure S2 Supporting 
Informations). 
 
2.8. Synthesis Procedures of Gd @)AuNPs: 
Synthesis of NP1  
10 ml of Gd solution (0.86mM) was mixed with 20 ml of 0.0001M aqueous HAuCl4 solution 
for 10 min. After this time, 250 µl of polyethylene glycol 600 diacid (PEG) was added under 
stirring for 5 min. After 10 min, 1.2 ml of NaBH4 (0.01M) was added drop-wise followed by 
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rapid stirring and kept without agitation for 2h. The resulting red-rose solution was 
centrifuged and purified as methodology described previously
29,31
. 
Synthesis of NP2  
NP2 were prepared under the same protocol of NP1. 
10 ml of Gd solution was mixed with 20 ml of 0.0001M aqueous HAuCl4 solution for 10 min. 
After this time, 250 µl of polyethylene glycol 600 diacid (PEG) was added under stirring for 5 
min; then 500µl of collagen (COL) and 1mlwas added under stirring at room temperature. 
After 10 min, 1.2 ml of NaBH4 (0.01M) was added drop-wise followed by rapid stirring and 
kept without agitation for 2h. The resulting violet solution was centrifuged and purified at the 
same conditions. 
Synthesis of NP3  
NP3 were prepared under the same protocol of NP2. 10 ml of Gd solution was mixed with 20 
ml of 0.0001M aqueous HAuCl4 solution for 10 min. After this time, 250 µl of polyethylene 
glycol 600 diacid (PEG) was added under stirring for 5 min; Then 500µl of collagen and 1ml 
of CHIT solutions were added under stirring at room temperature. After 10 min, 3mL (and/or 
1.2 ml ) of NaBH4 (0.01M) was added drop-wise followed by rapid stirring and kept without 
agitation for 2h. The resulting red-wine solution was centrifuged and purified at the same 
conditions. 
 
2.8.1Determination of Gd@AuNPs concentration 
Gd@AuNPs concentration was calculated mathematically in colloidal solution by Lambert-
Beer law (       ). In this equation A is the maximum absorbance  of the UV-visible 
spectrum,   is the molar extinction coefficient (equal to 3.07 × 1010 M-1 cm-1), C is the molar 
concentration of colloids and l is the optical length of cuvette (1 cm). The resulting C was 
multiplied for the dilution factor to obtain the concentration of colloids.
32
 
 
2.8.2 Purification and efficency  of Gd@AuNPs 
The encapsulation efficiency (percentage of Gd bound to  Au-surface) was evaluated as the 
difference between the initial Gd content and the amount of free  Gd in the filtrate after 
ultrafiltration (Ultrafree MC centrifugal filter units, 30,000 NMWL, Millipore, USA). The 
9 
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reaction efficiency resulted equal to 75%.Gd@AuNPs were dispersed at concentration of 
1.2×10
12
 particles/ml in 2.0 ml  PBS under physiological conditions. Dialysis was 
performed with membrane tubing with dialysis tubing Spectra/Por 3 (molecular weight 
cut-off 3500 Da, Serva Electrophoresis, Germany) with continuous stirring (150 rpm). 
2.9. Computational Details– DFT study 
The interaction energies were calculated using the ab initio plane-wave pseudopotential 
approach as implemented in the VASP code
22
. The Perdew-Burke-Ernzerhof (PBE) 
functional
23
 was chosen to perform the periodic DFT calculations with accuracy on the 
overall convergence tested elsewhere
24
. The valence electrons were treated explicitly and their 
interactions with the ionic cores are described by the Projector Augmented-Wave method 
(PAW),
28, 37-38
 which allows to use a low energy cut off equal to 400 eV for the plane-wave 
basis. The integration over the Brillouin zone was performed on the point, in all calculations. 
In the geometry optimizations at 0 K, the positions of all atoms in the supercell are relaxed in 
the potential energy determined by the full quantum mechanical electronic structure until the 
total energy differences between the loops is less than 10
-4
 eV. 
In order to account for the dispersion interaction in the system, DFT-D3
25
 was used, as 
implemented in VASP, which consists in adding a semi-empirical dispersion potential to the 
conventional Kohn-Sham DFT energy. 
In order to compare the results with the experiment, water was implicitly included in the 
calculations, by means of the PCM correction as implemented in VASP.
26
 
3. Results and discussion 
3.1. The formation mechanism of Gd-Au complex(Gd@Au) 
Several intermolecular interactions between organic compounds and metal chlorides were 
overcome in order to obtain new molecular systems for medical and bio-physical 
applications
3334
. The key to this study is to apply a Gd@Au chloride complex as building 
blocks of bimetallic nanoparticles under specific conditions of the reaction.  
For this aim, in the first step, GdCl3
*
6H2O and HAuCl4
*
3H2O were mixed in ultrapure water 
solution at room temperature (Scheme 1- panel s1). 
Figure 1 showed the absorption spectra fingerprint of each solution (GdCl3
*
6H2O, 
HAuCl4
*
3H2O) and the complex of them (Gd@Au). The UV-Vis Spectra showed typical 
10 
 
10 
 
spectra of HAuCl4
*
3H2O (black line) with 2 prominent peaks at 256 nm and 290 nm (black 
line in Figure 1A).  When GdCl3
*
6H2O was added to HAuCl4
*
3H2O solution, a chemical-
physical modification appeared evidenced, in the UV Vis Spectra (blue line in Figure 1A). 
The optical modification in the absorption spectra was indeed characterized by an intensity 
decrease and blue shift of the peak at 280 nm, due to the electronic transition associated with 
Gd-AuCl2
-
 ions upon complexation. The evolution of Gd@Au complex was still monitored 
under acidic and alkaline conditions by Localized Surface Plasmon technique (LSP). Figure 
S1 in Supporting Information, shreds of evidence of two absorption peaks at 242 nm and 
308 nm under acidic conditions (PBS; pH 4) compared to a singular peak at 235 nm under 
basic conditions (PBS; pH 9). This spectroscopic behaviour principally originates from the 
simultaneous participation of protonic and/or anionic groups into electronic transition bands 
conferring the appearance and/or disappearance of plasmon peaks in the UV –VIS spectra 
confirming the hybrid complex arrangement. 
Raman Spectroscopy (Figure 1B) also displays a  peak at 477 cm
-1
 due to Gd-Au-Cl and the 
disappearance of the peaks at 655 cm
-1
 and 550 cm
-1
 due to Gd-OH and Au-OH stretching. 
This spectroscopic behaviour was associated with π-π* electronic transitions due to the 
interactions between GdCl3 and AuCl2
- 
ions
8,35
 and this give better evidence of the complex 
formation  confirming the electronic delocalization thought the bimetallic complex
8
.  
3.2. The formation mechanism of core-shell Gd@Au NPs and the role of polymers as a 
stabilizing agent 
Many authors have realized the association between Au nanoparticles and Gd chelates in 
order to realize multimodal MRI/CT contrast agents
17
.For this purpose, other scientific 
investigations based onto  Gd-chelate-embedded gold nanorods,
36,37
 Gd-enriched DNA 
AuNPs conjugates
38
, and grafting Gd chelates on gold nanostructures as multimodal MRI/CT 
contrast agents have been carried out. Thanks to the small sizes of Gd chelates, a low 
magnetic centre Gd (III) payload for the particle prevents further bioconjugation and active 
targeting of AuNPs in biomedical applications
39
. In contrast to previous works, a novel 
Au(III)-Gd (III)complex, entrapped in polymeric chains was used as building blocks to form 
core-shell bimetallic nanoparticles (Gd@Au NPs).  
The synthesis of Gd@AuNPs  named NP1-NP2-NP3, was carried out by reducing 
tetraclororoauric acid  in the presence of gadolinium salt and different biocompatible 
polymers (PEG-diacid COL, CHIT) using sodium borohydride (NaBH4) as a reducing agent.  
Particles formation and growth were controlled by the amphiphilic character of the polymers 
11 
 
11 
 
and includes mains steps(scheme 1): (1) Complexation between GdCl3 and AuCl4
- 
to form 
gold-gadolinium clusters (Gd (III)-Au (III)) (scheme 1- panel s1), (2) adsorption of COOH-
terminated PEG polymer molecules onto Gd (III)-Au (III)complex and initial reduction to Gd 
(III)-Au (II), (3) interaction of collagen (COL) and Chitosan (CHIT) molecules respectively 
by electrostatic forces (scheme 1- panel s2), (4) complete reduction and growth of 
gadolinium-gold particles (scheme 1- panel s3). In the latter case, Gd@Au complex 
molecules are expected to be involved in the nucleation process and may, thus, influence the 
final shape and size of nanoparticles (NP1-NP2-NP3). 
3.3. Spectroscopic evaluationof Gd@Au NPs 
Previously G.Boyes et al.
40
 have grafted thiol-terminated polymer chains onto Gd 
nanocomposite through the coordination of the thiolate end group with Gd (III) ions
41
. 
The employment of polymer has shown a strong interaction between Gd composite and 
AuNPs
17,40,42
. In the present study, it was demonstrated that the introduction of the polymer as 
chelating surfactant, play a key role in the final form of bimetallic nanoformulation.  
TEM images of NP1embedded in a shell of PEG showed a metal core of diameter around 20 
± 1nm (Figure 2-A-a1 left over panel; low magnification) with a hydrodynamic layer of 
about 80 nm due to polymeric bimetallic complex (Figure 2-A right over panel; high 
magnification). Unlike nanostructures that were obtained with NP2.  
They exhibited a polyedric-like shape, embedded in a shell of PEG and COL, in which metal 
nanoparticles showed a diameter around 40 ± 2 nm (Figure 2-A-a2 middle panel; left low and 
right high magnification) with a hydrodynamic layer of about 5 nm. Similar polyhedral 
nanostructures have previously obtained thanks to the growing of macromolecules onto [110] 
gold facet
31
. In our case, it was supposed that during the growing process, COL and PEG 
undergoa conformational chemical arrangement responsible for adsorption onto the 
preferentially [110] gold facet, with consequently with the achievement of a polyhedral shape. 
TEM images to NP3 display a snowflake-like shape, embedded in a shell of PEG, COL, and 
CHIT with a diameter around 60 ± 2 nm (Figure 23-A-a3 left under panel; low 
magnification), with a layer average thickness of 3.5 ± 1nm (Figure 2-A right under panel; 
high magnification).  Beforehand we revealed the synthesis of comparable nanostructures 
utilizing dicarboxylic PEG, Chitosan
4b
, 
28 29
 and drugs
30 31 16c
, while characteristic snowflakes 
nanoparticles were acquired by consolidating protoporphyrin particles in the development 
solution of AuNPs
27
. On the basis of previous studies
252726
, it was assumed that this chemical 
12 
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behaviour, is attributed to a different adsorption behavior onto gold facets [1.1.0] of CHIT 
onto complex PEG-COL-GdAuCl2
-
, based on their different steric conformation of chemical 
groups during nucleation and growth process of Gd@AuNPs. Hence, it was assumed that , 
when the polymer ligands were added to the Gd@Au solution, the carboxylic group of 
polymer, being initially bound to Gd (III)-Au(III) clusters electrostatically, was embedded in 
dicarboxylic PEG in a mushroom conformation
2729
 and then bounded with COL and CHIT, 
respectively, in order to form hybrid- core-shell nanoparticles. Accordingly, it is possible to 
obtain different shapes and sizes of NPs, by varying the concentrations of reagents and the 
order of the added mixture in the reaction. In this way, the behavior of each polymer in the 
formation of bimetallic micelles during the growth process of nanoparticles can be modulated. 
Figure 3A, report absorption spectra of Gd@Au NPs, all characterized by peaks at 300 nm 
and 238 nm, and a surface plasmon band in the range 530-560 nm. The slow shift of the band 
position depends on the ratio of the gold salt and the capping materials during the reaction 
processes. NP1 (red line Figure 3 A) shows a plasmon peak at 560 nm. This peak is assigned 
to collective surface plasmon oscillation of the metal electrons in the conduction band, due to 
the interaction of electrons with the light of that wavelength. PEG can be used as stabilizing 
polymers due to the formation of coordination bands between Au (III) and Gd (III) ions with 
carboxylic groups. This chelation evenly better dispersed Au ions and Gd which were reduced 
to formGd@Au NPs of relatively uniform size. NP2 (blue line) and NP3 (green line) in 
Figure 3 A, shows a strong resonance band at around 222 nm, a weaker one at 300 nm. A 
shift and a strong decrease of the plasmon peak to 534 nm for NP2,  and 555 nm for NP3 was 
observed. This spectroscopic behaviour is due to the steric arrangement of PEG, COL, and 
CHIT as stabilizers during the synthetic process with the amine or carboxylic groups, 
respectively. We suppose that this phenomenon is due to electronic delocalization through 
polymer chains-metal complex and HOMO-LUMO transition, confirming that polymers 
(PEG, COL, CHIT) were effectively involved in the nucleation process and creates an 
interaction with Gd-Au.  
The NP sizes were confirmed by DLS measurements (Table S1 in Supporting Information). 
Zeta potential measurements show that Gd@AuNPs were colloidally stable at physiological 
pH. The synthesized Gd@AuNPs (NP1-NP2-NP3) show a negligible change in the LSP band 
position over a period of  72 h  in cell culture media (DMEM+10% FBS) (Figure S2 in 
Supporting Information). 
Raman spectroscopy and surface-enhanced Raman scattering were used to confirm the 
influence of Gd ions in Au-polymers nanoparticles. As described previously
23
, the presence of 
13 
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Gd ions provides to enhance the Raman signal of biomolecules (protein, natural polymer) 
capped onto gold nanoparticles (AuNPs). 
 
Raman spectra of Gd@AuNPs at 4.5 × 10
−4 
M are shown in Figure 3B. The region from 
1200 to 1550 cm
−1
 corresponds to the vibrations of N-H bending and C-N stretching, while 
the region between 1550 and 1750 cm
−1 
corresponds to the C=O stretching mode. The band 
observed near 836 cm
−1
, corresponds to vibrations of the aromatic ring. This enhancement is 
the result of the electric field around the gold nanoparticles that interact with collagen 
molecules, in the presence of gadolinium.  
The characteristic vibration mode for the amine group is located at 1630 cm
−1 
(highlighted 
band in Figure 3B). This band shows a Raman signal enhancement factor 40 times higher 
than that for free collagen
43
. The increment in the Raman signal of collagen could be due to a 
combination of three factors: (i) formation of well-defined hot-spots, where Gd (III) ions 
work as spacers between gold nanoparticles; (ii) the refractive index contrast produced by the 
presence of Gd (III) ions can cause an increment in the electric field around the nanoparticle  
producing,  a higher enhancement factor, and (iii) a charge transfer effect between gold 
nanoparticles and Gd (III) ions
44,45
.  
 
Gd@AuNPs were characterized by EDX microanalysis, in which the simultaneous presence 
of Gd and Au of all nanoparticles was qualitatively proven (Figure S3 Supporting 
Information). 
3.4. Kinetic release and disaggregation  
Release kinetics is a crucial parameter for biomedical application of NPs
30,46
. We decided to 
realize this study onto NP3 since it appears as the best candidate in terms of biological 
stability and, MRI contrast agent.  The release of Gd (III) as gold complex from NP3, was 
carried out in buffer solutions, under acidic (PBS; pH 4) and temperature conditions (37°C). 
The kinetic process was investigated by LSP and Raman spectroscopy. At pH 4.0, the release 
of 2% was noticed after 18 h and remained almost the same even after 180 h (Figure S4-A in 
the Supporting Information). The Raman band at 260 cm
-1
 was monitored to assess Gd (III) 
release from NP3. We performed our measurements each hour, noting a remarkable spectral 
change after 24 h, until complete-increase after 48 h (Figure S4-B in the Supporting 
Information). These findingsestablished that Gd (III) release was pH- and time-dependent 
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after long term . We believe that during incubation at pH 4, Gd@Au complex migrates in the 
PEG and CHIT chains and is released upon CHIT-PEG-GdAuCl2
-
. This scientific speculation 
can explain depolymerization and the change of size at different pH
47
 (Figure S4-C in the 
Supporting Information). We also observed a gradationalmodification of shape and size 
from nanoflowers of about 60 nm (as synthesized) (Figure S4-C panel a t=1h) to small 
nanospheres of about 5 nm (pH 4.0) (Figure S4-C panel d, t=72h). Between these two states, 
we relieve an intermediate one in which a morphological variation, as well as 
depolymerization from the original structure, was more evident (Figure S4-C panel b, c). We 
deduce that, under pH conditions, a strong change of shape and size of NP3 was made and Gd 
(III) was released as gold complex, as previously described for other experiments
27,47
. 
3.5. Computational results 
In order to investigate the interaction between the Au and  Gd precursors being considered as 
the very first nucleation step of the particles studied, a molecular geometry study at the DFT 
level corrected for dispersion interactions was performed. 
The precursors contain Cl
-
 and OH
-
 ligands. The ligand stoichiometry depends on the pH 
at which the synthesis is performed (Figure 4). As it was shown in one of our earlier studies 
on the Au precursor, the presence of Cl
-
 has an impact on the interaction that drives the 
nucleation and the interaction with its environment
48
. 
Both precursor molecules were positioned in each other’s neighbourhood (Au-Gd distance  7 
Å) followed by a geometry optimization. The different start geometries were investigated and 
at every metastable converged geometry an extra geometry optimization was performed until 
the total energy of the complex could not be lowered (stabilized) more. This procedure was 
undertaken for every combination of Cl
-
/OH
-
 and this for every relative position around the 
Au and the Gd center. The interaction energy is calculated as follows: 
 
Eint= E(HAu(OH)4-xClx···Gd(OH)3-yCly) – E(HAu(OH)4-xClx) – 
E(Gd(OH)3-yCly) 
(1) 
 
A graphical representation of the interaction energies (see eq. 1) between both metal 
complexes for every value of x and y is presented in Figure 5.  
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It can be seen that the presence of chlorine influences the interaction energy in a non-linear 
way (See e.g. red line in Figure 5). Indeed, the position and the number of Cl
-
 around each 
metal center, influence the stabilization of the complex. Moreover, it is interesting to note that 
one can divide the interactions into the following types: OH-OH, OH-Cl, Cl-Cl, and Gd-Au.  
The most stable configuration is found for GdCl3 interacting with HAuHau(OH)4, (i.e. x = 0, 
y = 3; -4.19 eV) (Figure 5 a). The presence of one Cl
-
 on the Au metal complex destabilizes it 
with 0.18 eV. From this result, one has to conclude that the H-bond interaction, that is 
expected to be formed between the complexes containing OH-groups do not compete with the 
metal-metal interaction in the complex and that Cl-Cl halogen bonding is, as expected weaker 
than a hydrogen bond. 
The destabilizing effect takes place after the addition of one Cl
-
 on the Au centre, even with 
the addition of a second and a third Cl
- 
. Nevertheless, the complexes do not reach the 
stabilization found for the HAu(OH)4…GdCl3 complex containing no Cl
-
 on Au. 
It is clear that this form of the precursor is the best for the Au precursor to interact with the 
Gd-precursor. Just for the sake of completeness, the HAu(OH)3Cl…Gd(OH)Cl2 is found the 
least stable one. However, two questions emerge: What is the stabilizing effect between the 
OH-Cl groups? And, what is the effect of the relative distribution of the Cl groups around the 
metal center of the interaction energy?  
The geometry of this complex shows us the Penta-coordination of Gd, the presence of 
bridging OH groups between Gd and Au and the shift of the H atom on a Au-OH group. Gd 
shows a high affinity for Cl, whereas Au prefers OH groups in our calculations. In general, 
the geometrical feature that destabilizes the complex is the presence of Cl between the metal 
centers. 
Having these stability trends in mind, what about the Cl content of the complexes in 
experimental conditions, especially, the role of the pH on the Cl content of the complexes ?. 
For the Au-precursor it is known that the optimal nucleation conditions for the formation of 
gold nanoclusters are in the range of 6 – 9. The gold complex at this optimal pH is shown in 
Figure 5b which corresponds to HAu(OH)Cl3. Surprisingly, it is this precursor type that has 
the strongest destabilizing effect.  
The gold complex was found to decrease its affinity for the Gd complex with an increasing 
number of Cl
-
 groups
48
. However, in the actual case of interaction with a Gd complex, the 
opposite trend is observed, i.e. GdCl3 interacts more strongly to Au(OH)3Cl than the Gd 
hydroxides (See Figure 3 in ref. 
48
). The explanation for this contrasting finding can be 
explained by electronegativity softness (polarizability) competition
49
. From the very low 
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electronegativity of Gd compared with the very high electronegativity of Au, i.e. 1.20 and 
2.54 on the scale of Pauling, respectively, it is clear that the polarity of the ligands is largely 
affected. Which can explain this opposite trend compared with Au or other more 
electronegative elements, such as Si, as was found in the case of silica (Si-OH groups). The 
hydroxylated Gd complex is found to more strongly interact than the chlorinated ones in 
accordance with the higher electronegativity of the oxygen atoms. In contrast, the interaction 
decreases upon chlorination resulting from the higher polarizability, charge capacity or 
softness of Cl
-
. 
The Cl
-
 surrounding Gd can attract more charge and thus interact more strongly. Earlier, 
delicate uncommon earth metal ion unequivocally reinforced with too hard donor oxygen 
atoms has been clarified by Pearson's HSAB principle
37
. With this trend in mind one can 
predict the optimal conditions to form Gd-Au clusters; i.e. the hypothetical pH conditions in 
which Gd is surrounded by Cl and Au by OH groups, i.e. basic conditions. 
3.6. In vitro cytotoxicity and relaxivity 
Viabilities of TIB-75 (hepatocytes) cells were evaluated using Alamar blue cytotoxic tests 
with increasing concentrations of nanoparticles. Figure 6 A shows mild toxicity at Gd 
concentrations above 0.2 mM concentration to 3.8 mM. The in vivo injected amount should, 
therefore, be inferior respectively from 2 mM of 38 mM of Gd.  
Relaxivities in solution were measured at 7 Teslas and were compared to Dotarem Gd 
complex commercial MRI contrast agent. Values of longitudinal and transverse relaxivities r1 
and r2 are given for these three types of objects in Figure 6 B and Table 1.  
Gd (III)complex contrast agents are well-known for their contrast agent properties in MR 
Imaging. They provide a hyper signal in appropriate T1 weighted MRI acquisition sequences. 
Gd@Au nanoparticles longitudinal relaxivity r1 increases with a better result for NP3, 
compared to the one of Gd (III)Dotarem and with smaller values as expected compared to free 
Gd (III) ions. Noteworthy, the r1 relaxivity values increase with the NP core sizes 19, 40 and 
60nm and hydrodynamic diameter of 100, 45 and 64 nm, for respectively NP1, NP2 and NP3; 
6,4 8,4 and 9,9 mM
-1
.s
-1
. which could be rationalized by water accessibility to Gd inner sphere 
thanks to the decreasingpolymer layer size of 80, 5 and 3,5nm which favouredoptimized 
water exchange rates and is the principal factor affecting r1 relaxivity for this 50-100nm 
size nanoparticles. These r1 values obtained at high magnetic field 7T are exceptionally high 
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for nanoparticles, as usual Gd CA’ s relaxivities are around 4mM-1.s-1 and that demonstrated 
the strong efficiency of these novel Gd@AuNPs as contrast agents (CA). 
Rotze etal. have performeda synthesis and characterization of a nanoconjugate CA by 
covalent binding of Gd(III) to thiolated DNA (Gd(III)-DNA), followed by grafting onto gold 
nanostars (DNA-Gd@stars)
50
. These 26 nm size conjugates display remarkable r1 with values 
up to 98 mM
-1
  at 1.4T. Besides, DNA-Gd@stars show efficient Gd(III) delivery and 
biocompatibility in vitro, evolvemeaningful contrast increase in solution when imaged at 7 T, 
and present potential in vivo applications. 
Table 1. Values of relaxivities r1 and r2 are expressed in (mM
-1
.s
-1
) measured at 7T, and 
corrected (second lines) from ICP AES elementary analysis (Institut Physique du Globe 
(IPG) ICP AES Facility, Paris); r2/r1 ratio is calculated to evidence the T1 type MRI contrast 
agent (>1). 
 
Contrast 
agents 
r1  r2 c r2/r1 
DOTAREM 4.0 3.9 1.1 
Gd (III) 9.5 5   
NP1 
6.47 9.03 1.40 
6.43 9.01 1.40 
NP2 
8.98 12.35 1.38 
8.49 12.23 1.44 
NP3 
9.79 14.29 1.46 
9.89 14.26 1.44 
 
Compared to the literature, the present nanoparticles display improved features in terms of 
MRimaging.Meade et al. have developed Gd(III)-gold nanoconjugates with varied chelate 
structure and nanoparticle-chelate linker length, showing good biocompatibility, high cellular 
internalization for cell tracking and MRI abilities at high 7T and 9,4T magnetic field. The r1 
relaxivities values at 7T of our Gd@AuNPs are higher by a factor of 1.5 to 2.4 compared to 
the small size commercial DOTA Gd and the Gd@AuNPs nanoconjugates of 25 nm size. 
3.7. In vivo biodistribution by MRI 
In vivo biodistribution studies were then accomplished to assess the kinetic behavior of the 
nanoparticles in mice and characterizetheir stealthiness property after intravenous injection. 
For further nanomedecine application in vivo, nanovectors should indeed circulate long 
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enough more than about 30 min into the bloodstream to be able to reach a potential targeted 
tissue, before being captured by the final reticulo-endoplasmicsystem, here liver and spleen. 
The NP size superior to 20 nm predicts a hepatic uptake. The natural uptake and clearance 
pathway for exogeneous scaffolds of a small size under 5 nm is the kidney. The proposed 
imaging method enabling such in vivo biodistribution is based on Dynamic Contrast 
Enhanced MR imaging with specific time observation adjustedfrom min to days. It allows 
following the organs uptake by kinetic imaging acquisitions to gain the whole process of 
nanoparticle elimination: liver uptake, remanence and clearance
51,52
. 
Figure 7(A-A1)and Table 2 summarize the kinetics of uptake and clearance of NP1with 
examples of MRI pictures illustrating the evolution of the signal versus time at each 
remarkable point (A: initial signal, B: increasingslope, C: plateau, D: decreasingsignal). The 
NP uptake by the liver results in an increase of signal in the liver up to 40% with an increase 
duration of 10 min corresponding to the NP circulation into the bloodstream. The plateau is 
reached during about 30 min meaning the accumulation of the NP in to the liver and the 
decreasing period during 48h corresponds to the clearance time. 
The biodistribution inother organs (spleen and kidney) were recorded by In vivo DCE MRI at 
7T and showed in Figure S5 in Supporting Informations. Semi quantitative kinetic 
parameters can be deduced from the DCE curves. The biodistribution in the spleen looks like 
the liver one. In the kidney, the uptake is immediate corresponding to the perfusion through 
the cortex and the clearance took place after 3 to 5 hours post injection. The CA is not 
eliminated by the glomerular filtration as shown by the expected lack of medullar and bladder 
signal. 
It is of interest to compare these results with the biodistribution of the small size commercial 
contrast agent DOTAREM ( Table 3). Indeed, as Figure S6 displays, the uptake in kidney is 
quick and the clearance phase immediately follows during 3h, corresponding to a half life of 
90 min. In liver, the clearance is also rapid within about 1hour, corresponding to a vascular 
complementary circulation. To sum up, DOTAREM is eliminated more quickly about 10 
times faster than the NP1. The mid size and in particular the polymer PEG coating of the NP 
could rationalized its long circulating behavior, as expected from the PEG stealthiness ability 
showing the efficiency of the novel NP as a contrast agent for biomedical applications. 
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Table 2. Timings of biodistribution of the NP1measured in vivo from DCE MRI in mice : 
organs 
Capture 
slope 
T0 
(minutes) 
Tmax 
(minutes) 
Imax 
plateau time 
(minutes) 
clearance 
time 
(minutes) 
Spleen progresssive 39 180 1.87 3h to 24h >24h 
Liver progressive 6 21 1.08 10 to 40 > 24h 
Kidney rapid 3 12 1.02 6 to 40 min 6h to 24h 
       
organs Clearance time 
10mM Gd DOTAREM NP1 
kidney 3h >6h to 
24h 
liver 1h 48h 
Table 3. Comparison of timings of biodistribution with commercial DOTAREM 
 
4. Conclusion 
In this paper the development of new chemical polymeric core-shell nanostructures, whose 
optical and morphological properties are optimized for their application in therapeutic 
targeting, diagnosis and therapy. In contrast to previous works, a new strategy of gadolinium 
complexes to gold ions, and then stacking with biopolymer matrix was employed. Chemical-
Physical characterization studies were led broadly and completely explained the arrangement 
system of the nanostructure just as, the conformational changes related to such procedures. 
We demonstrated that Gd@AuNPs have some advantages to display hepatocytes in the liver. 
Particularly, these nanoconjugates give a good cellular uptake of several quantities of Gd 
@NPs into cells, while preserving a T1 contrast inside cells that provide a robust in vivo 
detection using T1-weighted MR images. 
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After in vitro assays of cytotoxicity and imaging, in vivo assays of dynamic 
biodistribution were recorded showing liver, spleen, kidney/blood biodistribution and blood 
stealthiness. Given these encouraging results, this bimetallic core-shell-nanomaterial system 
representsa veritable promise as a therapeutic entity in the field of medicinal applications. 
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